Healthcare & Life Sciences
Aglaia Therapeutics
France
About
Aglaia Therapeutics is a biotechnology company focused on discovering and developing immune-oncology drugs that target the innate immune system to treat cancer.
Explore Aglaia Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.